10A -The Michigan Daily -Thursday, March 13, 2003 Shaved heads not in the cards for cagers By Chris Burke Daily Sports Editor With no shot at going to the NCAA Tournament, the Michigan men's basketball team is prepared to do anything it takes to prolong its run at the Big Ten Tournament that begins Friday night for the Wolverines. Well ... almost anything. "I know I'm not shaving my head," freshman Daniel Horton said. "My head is shaped kind of funny - I've got a hump and a dip in my head, so I'm not shaving mine." Despite the ever-growing tradition among NCAA teams to make a team-wide trip to the bar- bershop just prior to tournament play, the Wolver- ines haven't made any plans to grace the United Center court in Chicago with a major fashion statement reminiscent of the Fab Five. "We don't really have anything yet," center Gra- ham Brown said. "I hope they don't bring up any- thing (like shaving our heads), because I don't think I'll be dealing with that." Senior tri-captain Rotolu Adebiyi agreed that Brown staying away from the whole head-shaving idea was a smart move on the freshman's part. "I don't know if I'm too excited about seeing Graham with a shaved head," Adebiyi said. "I'm open to whatever - if they want to do something, that's fine with me. I'd like to keep my hair as long as I can, but you never know what will happen. "Overall, we're a team of handsome young men, and I think we could pull off the look." While the shaven look has become prominent in basketball recently, the Michigan hockey team implemented a variation on the style for last year's playoffs - the Wolverines opted to keep their hair, but dye it blonde. Senior Gavin Groninger said that his high school team opted to go blonde for its playoffs, but the rest of the Wolverines would rather keep that idea on the shelf as well. "I can't go with the blonde hair," senior LaVell Blanchard said. "Sorry, I just can't do dyed blonde." The most popular option among team members appeared to be a Big Ten Tournament title going hand-in-hand with the shaving of coach Tommy Amaker's head. "We've been talking about that all year," Hor- ton said. "That if we win the Big Ten Tourna- ment, we should shave coach Amaker's head, but I don't know." It's unclear whether or not Amaker has agreed to a deal that would leave him bald for a while. Blanchard claimed that the Wolverines had a chance to clean Amaker's head, but couldn't finish the job. "We had an opportunity to do that one, but did- n't get it done," Blanchard said suspiciously. "I can't say (why) ... but we didn't get it done." While the Wolverines don't have any plans as of now to show camaraderie via baldness as of yet, that doesn't necessarily mean that something won't happen before Michigan hits the court to take on either Indiana or Penn State late tomorrow night. "You know it's tournament time, so maybe the night before, in the hotel, guys will start thinking of stuff," Adebiyi said. "You never know what will happen." SIKORA Continued from Page 8A that you lost those six games. But his team had bought into his system. This was clear from day one. Amaker's ability to motivate his players looks even more impressive given what happened at St. Bonaventure. The Bonnies decided not to play in the final two games of the season when they found out they couldn't go to the postseason. Amaker's play- ers knew the entire season there would be no promised land, but they never quit working. The Wolverines had bought into Amaker as a person, a leader and a mentor. The system worked, and Michigan is now a winning program again - which is how it will proba- bly stay for years to come. Ryan's Badgers had their share of struggles early in the season too, and Ryan did a tremendous job of pulling them out of a hole. But to compare the situation in Wisconsin with that in Michigan would be like comparing night and day. Unlike Ryan's situation, Amaker's task was daunting and would have over- whelmed most people. Plus, with Wisconsin coming off of a confer- ence title, the urgency to change was much stronger in Ann Arbor. Amaker deserved to be recog- nized as Coach of the Year for the about-face he pulled with Michigan this season. His team's late-season struggles because it wore down should not factor into the decision. In the big picture, he did more for his program than any other coach did for their this season. He deserved to be recognized for his perseverance and faith in his own methods and his players. Regardless of wins and losses, Michigan basketball has changed for the better. Naweed Sikora can be reached at nsikora@umich.edu LIS aOSINS/aUly Michigan freshman Graham Brown doesn't think he would look good with a shaved head, and neither do his teammates. 0 'M' proving itself before Big Ten Championships By Gabriola D'Jaen For the Daily With only three invitationals left before the Big Ten Championships arrive, the Michigan women's golf team is proving to its competition and itself that it is a realistic threat. After the Wolverines' hopes for improv- ing their score at the Northrop Grumman Regional Challenge were dashed due to weather conditions, coach Kathy Teichert added the California-Irvine Anteater Invitational to the team's schedule.' "This was a great experience for us, the timing was perfect, and it just happened to fall in a perfect spot," Teichert said. The two-day tournament, held in Coto de Caza, Calif., proved to be an opportunity for the women to shine, and resulted in the Wolverines' second best fin- ish of the season. When the final 54-holes of golf had been played, the Wolverines were in third place with a 929 total, following first-place California-Irvine by four strokes, and a mere two strokes behind Cal State- Northridge. Senior Kim Benedict showcased her talent during this tournament - especially in the second round. Benedict tied her season-best score with a two-under par 70. Benedict finished in a tie for fifth place, fol- lowed by freshman Amy Schmucker, who finished 13th with 17-over-par for the tournament. Both women carded their second best total of the season - Bene- dict with 224, one shot off her season-best, and Schmucker with 233. "The more I put myself into a position to finish well and the more pressure I put on myself to perform, the better I will be in the future," Benedict said. The Wolverines usually count on sophomore Laura Olin to assist Benedict in leading the team. After a score of 169 after two rounds, Olin was far behind the lead. She shot a 76 in the final round, but was unable to repair the damage from her second round of 88. Olin finished in 29th place with 245 total stokes. Stephanie Stasik made a notable effort - her 22 over- par landed her in 21st place - and Courtney Goebel tied her season-best round with a 77 in the second round. The Wolverines have faced disappointment during final rounds this season. The team struggled during its last tournament at the Central District Invitational in Florida, dropping three spots during the last day to tie for eighth place. But the Wolverines maintained a level of consistency throughout this tournament that displayed their increasing dependability and stability. "I thought we put ourselves in very good positions to actually win the tournament," Teichert said. "It was great to actually have a chance to win it, and I think that can help our program and our players." The California-Irvine Invitational was comprised of 13 teams. Among them were two frequent competitors: Texas Tech, who placed higher than the Wolverines in the last tournament, and Iowa State. The Wolverines will confidently head down to Austin, Texas in less than two weeks for the Betsy Rawls Invitational over March 24-26. The field will consist of competitive teams from the Midwest and South, and should provide a challenging and aggres- sive atmosphere for the Wolverines. "The field will be a little more difficult and more competitive, which is a good thing," Teichert said. "I'm expecting our players to improve from each tournament and step up to the challenge." While improving at each tournament is on Michi- gan's agenda, there are other motives to attending tour- naments. As Benedict put it, "It also is just another opportunity to see grass, which isn't a bad thing from where we come from." DANNY MOLOSHOK/Daily The Michigan women's golf team had its second best finish of the season this week at the California-Irvine Invitational. EXTER Continued from Page 8A Thomson. Though Masters was fine, there was some chatter in the crowd about how safe goalies' masks are. "(The equipment) is definitely setup to (last)," Montoya said. "But you get goalies and forwards messing with their equipment, and they tend to adjust it to their comfort. They loosen it up, and maybe that's what happened." Though a case like Exter's was a rare event, considering forwards and goalies go after the same loose puck all the time - "Usually I lower my shoulder and I go right after them," Montoya said - there have been situations where it was- n't an accident. "Last year, I was out for a couple weeks,"Montoya said. "There were a couple scrums (before the incident), and fights starting. I guess one guy didn't really want to fight me (fairly), so they sent one of their players - two-on-one - who slid the puck right on through. The guy in the middle left the puck and cante after me. My head flipped back, helmet flipped off, I hit the crossbar and hit the ice. I had a concussion." Still, there's not much that can be done to protect that. "They don't make goalie masks with the idea that they're going to be hit by knees and skates," Michigan coach Red Berenson said. "You can't protect against everything" As the playoffs approach for the Wolverines, there is little doubt that Exter will be on the minds of many. "It looked like a harmless collision to tell the truth ... it's just crazy," said Woodford, after seeing the film. "It makes you step and look back at how lucky you are to be playing this game and to be healthy. Hopefully, he'll get through it and just have a regular life again." -TheAssociatedPress and United States College Hockey Online contributed to this report. 6 I I L 91 :I: Contraceptive Injection IEAirtk con~trol you.-tkir-~k a~out jus-t +x a year medroxyprogesterone acetate injectable suspension DEPO-PROVERA Contraceptive Injection (medroxyprogesterone acetate injectable suspension, USP) This product is intended to prevent pregnancy. It does not protect against HIV infection (AIDS) and other sexually transmitted diseases. What is DEPO-PROVERA Contraceptive injection? DEPO-PROVERA Contraceptive Injection is a form of birth control that is given as an intramuscular injection (a shot) in the buttock or upper arm once every 3 months (13 weeks). To continue your contraceptive protection, you must return for your next injection promptly at the end of 3 months (13 weeks). DEPO-PROVERA contains medroxyprogesterone acetate, a chemical similar to (but not the same as) the natural hormone progesterone, which is produced by your ovaries during the second half of your menstrual cycle. DEPO-PROVERA acts by preventing your egg cells from ripening. If an egg is not released from the ovaries during your menstrual cycle, it cannot become fertilized by sperm and-result in pregnancy. DEPO-PROVERA also causes changes in the linrngofyouruterus that make it less likely for pregnancy to occur How effective is DEPO-PROVERA Contraceptive Injection? The efficacy of DEPO-PROVERA Contraceptive Injection depends on followin the recommended dosage schedule exactly (see "How often do I get my shot of DEPO-PR OERA Contraceptive Injection?"). To make sure you are not pregnant when you first get DEFPO ROVERA Contraceptive Iejection, your first injection must be given ONLY during the first 5 days of a normal menstrual period: ONLY within the first 5 days after childbirth if not breast-feeding and, if exdusively brrast-feeding, ONLY at the sixth week after childbirth. It is a lort -nrm injectable contractptivc whcn administered at 3-month (13-week) intervals. DE OPROVERA Contraceptivc 1njecton is over 99% effective, making it one of the most reliable methods of birth control available. Tis Imans that the average annual pregnancy rate is less than one for every 10Of women who usc 1liHfO-PROVE PA. The effectiveness of most contraceptive mneth dss in art on how relably earh woman rses tire method. The effectiveness of DEPO PROVERA depends only on thc patient returning every 3 months (13 weeks) for her next injection. Your Iealth-care provider will help you compare DEPO-PROVERA with other contraceptive mretds and give you the information you need in order to decide which contraceptive method is the right choice for you. The following table shows the percent of women who got pregnant while using different kinds of contraceptive methods. It gives both the lowest expected rate of pregnancy the rate expected in women who use each method exactly as it should be used) and the typical rate of pregnancy (which includes women who became pregnant because they forgot to use their birth control or because they did not follow the directions exactly). Percent of Women Experiencing an Accidental Pregnancy in the First Year of Continuous Use - if you have had cancer of the breast - if you have had a stroke " if you have or have had blood clots (phlebitis) in your legs if you have problems with your liver or liver disease " if you are allergic to DEPO-PROVERA (medroxyprogesterone acetate or any of its other ingredients). What other things should I consider before using DEPO-PROVERA Contraceptive Injection? You will have a physical examination before your doctor prescribes DEO-PROVERA. It is important to tell your health-care provider if you have any of the following: " a family history of breast cancer " an abnormal mammogram (breast x-ray), fibrocystic breast disease, breast nodules or lurips, or bleeding from your nipples " kidney disease - irregular or scanty menstrual periods " high blood pressure + migraine headaches " asthma " epilepsy (convulsions or seizures) ' diabetes or a family history of diabetes " a history of depression * if you are taking any prescription or over the-counter medications This product is intended to prevent pregnancy. It does not protect against transmission of HIV (AIDS) and other sexually transmitted diseases such as chiamydia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphilis. What if I want to become pregnant after using DEPO-PROVERA Contraceptive Injection? Because DEPO-PROVERA is a Iong-acting birth control method, it takes some time after your last injection for its effect to wear off. Based on the results from a large study done in the United States, for women who stop using DEPO-PROVERA in order to become pregnant, it is expected that about half of those who become pregnant will do so in about 10 months after their last injection; about two thirds of those who become pregnant will do so in about I2 monthy; about 83% of those who become pregnant will do so in aout 15 months; and about 93% of those who become pregnant will do so in about I8 months after their last injection. The length of time you use DEPO-PROVERA has no effect on how lon it takes you to become pregnant after you stop using it. What are the risks of using DEPO-PROVERA Contraceptive Injection? I Irregular Menstrual Bleeding The side effect reported most frequently by women who use DEPO-PROVEA for contraceotion is a change in their normal menstrual cycle. During the first year of using DEPO-P OVEPA, you might have one or more of the following changes: irregular or unpredictable bleeding or spotting, an increase or decrease in menstrual bleeding, or nro bleeding at all. Unusually heavy or continuous bleeding, however; is not a usual effect of DEPO-PROVERA: and if this happens, you should see your health-care provider right away With continued use of DEPO-PROVERA, bleeding usually decreases, and many women stop having periods completely, In clinical studies of DEPO-PRVERA. 55% of the women studied reported no menstrual bleeding (amenorrfrea) after I year of use, and 68% of the women studied reported no menstrual bleeding after 2 years of use. The reason that your periods stop is because DEPO PROVERA causes a resting state in your ovaries. When your ovaries do riot release an egg monthly, the regular monthly growth of the lining of your uterus does not occur arid, therefore, the bleeding that comes with your normal menstruation does not take place. When you stop using DEPO-PROVERA your menstrual period will usually in time, return to its normal cycle. 2.Bone Mineral Changes Use of DEPO-PROVERA may be associated with a decrease in the amount of mireral stored in 6.0ther Risks Women who use hormone-based contraceptives may have an increased risk of blood clots or stroke. Also, if a contraceptive method fails, there is a possibility that the fertilized egg will begin to develop outside of the uterus (ectopic pregnancy). While these events are rare, you should tell your health-care provider if you have any of the problems listed in the next section. What symptoms may signal problems while using DEPO-PROVERA Contraceptive Injection? Call your health-care provider immediately if any of these problems occur following an injection of DEPO-PROVERA: " sharp chest pain, coughing up of blood, or sudden shortness of breath (indicating a possible clot in the lung) sudden severe headache or vomiting, dizziness or fainting, problems with your eyesight or speech, weakness, or numbness in an arm or leg (indicating a possible stroke) . severe pain or swelling in the calf (indicating a possible clot in the leg) - unusually heavy vaginal bleeding - severe pain or tenderness in the lower abdominal area ersistent ain, pus, or bleeding at the injectionsite Wh~at are the possible side effects of DEPO-PROVERA Contraceptive Injection? l.Weight Gain You may experience a weight gain while you are using DEPO-PROVERA. About two thirds of the women who used DEPO-PROVERA in clinical trials reported a weight gain of about 5 pounds during the first year of use. You may continue to gain weight after the first year Women in one large study who used DEPO-PROVERA for 2 years gained an average total of 8,1 pounds over those 2 years, or approximately 4 pounds per year. Women who continued for 4 years gained an average total of I 3.8 pounds over those 4 years, or approximately 3.5 pounds per year Women who continued for 6 years gained an average total of 16.5 pounds over those 6 years, or approximately 2.75 pounds per year; 2 Onfrr Side Effects In a clinical study of over 3,900 women who used DEPO-PROVERA for up to 7 years, some women reported the following effects that may or may not have been related to their use of DEPO-PROVERA: Irregular menstrual bleeding, amenorrhea, headache, nervousness, abdominal cramps, dizziness, weakness or fatigue, decreased sexual desire, leg cramps. nausea, vaginal discharge or irritation, breast swelling and tenderness, bloating, swelling of the hands or feet, backache, depression, insomnia, acne, pelvic pain, no hair growth or excessive hair loss, rash, hot flashes, and joint pain. Other problems were reported by very few of the women in the clinical trials, but some of these could be serious. These include convulsions, jaundice, urinary tract infections, allergic reactions, fainting, paralysis, osteoporosis, lack of return to fertility, deep vein thrombosis, pulmonary embolus, breast cancer or cervical cancer If these or any other problems occur during your use of DEPO-PROVERA, discuss them with your health-care provider Should any precautions be followed during use of DE PO-PROVERA Contraceptive Injection? .Missed Periods During the time you are using DEPO-PROVERA for contraception, you may skip a period, or your periods may stop completely If you have been receiving your DEPO-PROVERA injections regularly every 3 months (I3 weeks), then you are probably not pregnant. However, if you think that you may be pregnant, see your health-care provider. 2Lfborttory Test Interactions if you are scheduled for any laboratory tests, tell your health-care provider that you are using D EPO-PROVERA for contraception. Certain blood tests are affected by hormones such as DEPO-PROVEPA. ru Interactions C yta ren (aminoglutethimide is an anticancer drug that may significantly decrease the effectiveness of DEPO-PRO ERA if the two drugs are given during the same time. 4.Nursing Mothers - FOOD FOR THOUGHT Vietnam/Iraq Comparisons The Iraq protestors that I have talked to say they feel that they must do something. If their protests demanded that Saddam Hussein suc- cumb to growing Arab pres- sure and go into exile, might he not be forced into it, thus averting war? Gary Lillie & Assoc., Realtors www.garylilie.com SC9OSIR EP.RS THURSDAY NIGHTS Killians &Coors Light Pitchers 9 -10 pm $1.50 10-close $2.50 Lowest Method Expected Typical 1)1Er) P'ROR A ______il 0. - - ----- --- - Iemai strilizatal n ii 11 0A4 Maie sien^izat 0 I 0. S Oril niriia i'rvi (psI) 3 irimbirnei it I P~yrosnrgen onirly II5 ill 3 I